Arnab Pal

Biographic Data

ID9066931
NAMEArnab Pal
GIVEN NAMESArnab
FAMILY NAMEPal
SIGNATUREPAL A
AFFILIATIONSClinton Foundation
ORCID0000-0003-2161-7520
VERIFIEDYes
TOTAL WORKS2
TOTAL CITATIONS0
WORKS AS AUTHOR2
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2022
LATEST PUBLICATION YEAR2025
H-INDEX0

  • Adverse drug reactions in tuberculosis treatment

    Open AccessRidhima Sodhi, Tunisha Kapoor et al.ARTICLEPLOS Global Public Health2025

    Adverse drug reactions (ADRs) remain a major barrier to successful tuberculosis (TB) treatment. They undermine adherence, prolong morbidity, and increase the risk of treatment failures and mortality. Yet, evidence on their incidence, duration, and management across diverse patient groups remains limited. We conducted a mixed-methods study to address this gap, using a representative sample of patients from six states in India. Specifically, we com…

  • “Dost” Model to Link and Support Drug Resistant TB Patients From Private Sector

    Open AccessVindhya Vatsyayan, Theresa Pattery et al.ARTICLEFrontiers in Public Health2022

    Background: The National TB Elimination Programme (NTEP) has quite successfully involved private sector for referral of presumptive drug resistant TB (DR-TB) patients for molecular testing and referral for DR-TB management. There was a challenge as all the referred patients were not reaching to the facilities. A "DOST" intervention model was implemented to strengthen the patient care pathway. We conducted this study to describe the patient care c…